CrossrefInfokarte
Dichotomous assessments of homologous recombination deficiency are insufficient predictive biomarkers for the PARP inhibitor treatment of ovarian cancer
Clinical and Translational Medicine · 2026-11 · 16 (11)
DOI: 10.1002/ctm2.70890 ↗Abstract
Kein Abstract verfügbar.
EUVIMED